The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »
mypharmacynews.com
Home »
The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »A JAMA journal is retracting and replacing a 2020 paper which linked exposure to nonionizing radiation — think cellphones, Bluetooth
Continue reading »Dyspraxia is a developmental disorder. It can affect all phases and aspects of a child’s growth including physical, social, memory,
Continue reading »